47
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Should dendritic cell-based tumor vaccination be incorporated into standard therapy for newly diagnosed glioblastoma patients?

&
Pages 1173-1176 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xuan Wang, Hong-Yang Zhao, Fang-Cheng Zhang, Yun Sun, Zhi-Yong Xiong & Xiao-Bing Jiang. (2014) Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review. Cancer Investigation 32:9, pages 451-457.
Read now

Articles from other publishers (3)

Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher & Wilfried Stuecker. 2023.
Stephanie Seré, Ulrique Vounckx, Jin Won Seo, Ilse Lenaerts, Stefaan Van Gool & Jean-Pierre Locquet. (2020) Proof of Concept Study: Mesoporous Silica Nanoparticles, From Synthesis to Active Specific Immunotherapy. Frontiers in Nanotechnology 2.
Crossref
Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan van Gool & Steven de Vleeschouwer. (2013) Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?. Cancers 5:4, pages 1020-1048.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.